Skip to main content

CORRECTION article

Front. Immunol., 25 July 2024
Sec. Vaccines and Molecular Therapeutics

Corrigendum: Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity

  • 1Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States
  • 2William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN, United States

In the published article, there was an error in the Funding statement. The published Funding statement stated that “The author declares financial support was received for research, authorship, and/or publication of this article”, which is not correct. The correct Funding statement appears below.

FUNDING

The author declares no financial support was received for research, authorship, and or publication of this article. The article processing fee was paid by Invivyd, Inc.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: COVID-19, immunocompromised, SARS-CoV-2, prevention, treatment

Citation: Razonable RR (2024) Corrigendum: Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity. Front. Immunol. 15:1440571. doi: 10.3389/fimmu.2024.1440571

Received: 29 May 2024; Accepted: 31 May 2024;
Published: 25 July 2024.

Approved by:

Frontiers in Immunology Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Razonable. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Raymund R. Razonable, UmF6b25hYmxlLlJheW11bmRAbWF5by5lZHU=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.